No

Carbonic Anhydrase Inhibitor; Diuretic, Carbonic Anhydrase Inhibitor; Ophthalmic Agent, Antiglaucoma

Adjunct in treatment of open-angle glaucoma and perioperative treatment for angle-closure glaucoma

C

Severe pulmonary obstruction; severe renal impairment; hypersensitivity to dichlorphenamide

>10%:

Central nervous system: Fatigue, malaise

Gastrointestinal: Diarrhea, anorexia, metallic taste

Genitourinary: Polyuria

1% to 10%:

Central nervous system: Mental depression, drowsiness

Renal: Renal calculi

Increased lithium excretion and altered excretion of other drugs by alkalinization of the urine

Adults: Oral: 100-200 mg to start followed by 100 mg every 12 hours until desired response is obtained; maintenance dose: 25-50 mg 1-3 times/day

Sedation is common; may cause depression

May rarely cause bone marrow suppression; use caution with clozapine and carbamazepine; may increase the excretion of lithium but should not be used to treat lithium toxicity

No information available to require special precautions

No effects or complications reported

Report numbness or tingling of extremities to physician; ability to perform tasks requiring mental alertness and/or physical coordination may be impaired; take with food if GI upset occurs; notify if flank pain or rash occurs

Monitor electrolytes

Tablet: 50 mg